Risks and benefits of statins in lupus erythematosus

被引：7

作者：

Noël, B

机构：

来源：

ARCHIVES OF INTERNAL MEDICINE | 2004年 / 164卷 / 01期

关键词：

D O I：

10.1001/archinte.164.1.107-b

中图分类号：

R5 [内科学];

学科分类号：

1002 [临床医学]; 100201 [内科学];

摘要：

引用

收藏

页码：107 / 108

页数：2

相关论文

共 11 条

[1]

LUPUS-LIKE SYNDROME ASSOCIATED WITH SIMVASTATIN [J].

BANNWARTH, B ;

MIREMONT, G ;

PAPAPIETRO, PM .

ARCHIVES OF INTERNAL MEDICINE, 1992, 152 (05) :1093-1093

[2]

Bruce IN, 1999, J RHEUMATOL, V26, P2137

[3]

Drug-induced lupus-like syndrome associated with severe autoimmune hepatitis [J].

Graziadei, IW ;

Obermoser, GE ;

Sepp, NT ;

Erhart, KH ;

Vogel, W .

LUPUS, 2003, 12 (05) :409-412

[4]

Lupus-like syndrome associated with simvastatin [J].

Hanson, J ;

Bossingham, D .

LANCET, 1998, 352 (9133) :1070-1070

[5]

Inhibitors of HMG-CoA reductase sensitize human smooth muscle cells to Fas-ligand and cytokine-induced cell death [J].

Knapp, AC ;

Huang, JW ;

Starling, G ;

Kiener, PA .

ATHEROSCLEROSIS, 2000, 152 (01) :217-227

[6]

Statins as a newly recognized type of immunomodulator [J].

Kwak, B ;

Mulhaupt, F ;

Myit, S ;

Mach, F .

NATURE MEDICINE, 2000, 6 (12) :1399-1402

[7]

Atorvastatin-induced dermatomyositis [J].

Noël, B ;

Cerottini, JP ;

Panizzon, RG .

AMERICAN JOURNAL OF MEDICINE, 2001, 110 (08) :670-671

[8]

The cardiovascular burden of lupus - A complex challenge [J].

Schattner, A .

ARCHIVES OF INTERNAL MEDICINE, 2003, 163 (13) :1507-1510

[9]

Drug-induced, Ro/SSA-positive cutaneous lupus erythematosus [J].

Srivastava, M ;

Rencic, A ;

Diglio, G ;

Santana, H ;

Bonitz, P ;

Watson, R ;

Ha, E ;

Anhalt, GJ ;

Provost, TT ;

Nousari, CH .

ARCHIVES OF DERMATOLOGY, 2003, 139 (01) :45-49

[10]

Stoebner PE, 2003, ANN DERMATOL VENER, V130, P187